Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
60.34 USD | +4.24% | -8.06% | -28.11% |
05-09 | Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating | MT |
05-08 | Cytokinetics Q1 Net Loss Narrows, Revenue Declines | MT |